Design, synthesis and docking studies of some novel (R)-2-(4′-chlorophenyl)-3-(4′-nitrophenyl)-1,2,3,5-tetrahydrobenzo[4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents
- 1 August 2014
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 83, 245-255
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Identification of a New Class of FtsZ Inhibitors by Structure-Based Design and in Vitro ScreeningJournal of Chemical Information and Modeling, 2013
- The therapeutic journey of benzimidazoles: A reviewBioorganic & Medicinal Chemistry, 2012
- Surflex-Dock: Docking benchmarks and real-world applicationJournal of Computer-Aided Molecular Design, 2012
- Novel Trisubstituted Benzimidazoles, Targeting Mtb FtsZ, as a New Class of Antitubercular AgentsJournal of Medicinal Chemistry, 2010
- Discovery of Anti-TB Agents that Target the Cell-Division Protein FtsZFuture Medicinal Chemistry, 2010
- 5-Nitro-2-furoic acid hydrazones: Design, synthesis and in vitro antimycobacterial evaluation against log and starved phase culturesBioorganic & Medicinal Chemistry Letters, 2010
- Structure−Activity Relationships of Antitubercular Nitroimidazoles. 2. Determinants of Aerobic Activity and Quantitative Structure−Activity RelationshipsJournal of Medicinal Chemistry, 2009
- Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate SynthaseJournal of Chemical Information and Modeling, 2009
- Discovery of Novel Nitrobenzothiazole Inhibitors for Mycobacterium tuberculosis ATP Phosphoribosyl Transferase (HisG) through Virtual ScreeningJournal of Medicinal Chemistry, 2008
- Structure of Mycobacterium tuberculosis FtsZ Reveals Unexpected, G Protein-like Conformational SwitchesJournal of Molecular Biology, 2004